DOP2006000035A - Preparación farmaceútica para la anticoncepción oral - Google Patents
Preparación farmaceútica para la anticoncepción oralInfo
- Publication number
- DOP2006000035A DOP2006000035A DO2006000035A DO2006000035A DOP2006000035A DO P2006000035 A DOP2006000035 A DO P2006000035A DO 2006000035 A DO2006000035 A DO 2006000035A DO 2006000035 A DO2006000035 A DO 2006000035A DO P2006000035 A DOP2006000035 A DO P2006000035A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- pharmaceutical preparation
- dienogest
- conception
- ethinylestradiol
- oral anti
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 3
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 4
- 229960002568 ethinylestradiol Drugs 0.000 abstract 4
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 abstract 3
- AZFLJNIPTRTECV-FUMNGEBKSA-N dienogest Chemical compound C1CC(=O)C=C2CC[C@@H]([C@H]3[C@@](C)([C@](CC3)(O)CC#N)CC3)C3=C21 AZFLJNIPTRTECV-FUMNGEBKSA-N 0.000 abstract 3
- 229960003309 dienogest Drugs 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000027758 ovulation cycle Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Una preparación farmaceutica para la anticoncepción oral, que contiene como primer componente de principio activo 17 -cianometil-17- -hidroxiestra-4,9-dien-3-ona (dienogest) en una dosis diaria de 1,5 mg de dienogest y como segundo componente de principio activo 17 -etinilestradiol (etinilestradiol) en una dosis diaria de 0,015 6 0,020 mg de etinilestradiol a 2,0 mg de dienogest y 0,015 mg de etinilestradiol, se administra junto con uno o varios portadores farmaceuticamente aceptables en al menos 21 dias de un ciclo menstrual de 28 dias. Ademas, la preparación farmaceutica contiene 7 o menos unidades de dosis diarias sin principio activo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05003179A EP1690543A1 (de) | 2005-02-15 | 2005-02-15 | Pharmazeutisches Präparat zur Kontrazeption |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2006000035A true DOP2006000035A (es) | 2006-09-15 |
Family
ID=34933759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2006000035A DOP2006000035A (es) | 2005-02-15 | 2006-02-13 | Preparación farmaceútica para la anticoncepción oral |
Country Status (20)
| Country | Link |
|---|---|
| EP (2) | EP1690543A1 (es) |
| JP (1) | JP2008527018A (es) |
| KR (1) | KR20070086380A (es) |
| CN (1) | CN101119732A (es) |
| AR (1) | AR053545A1 (es) |
| AU (1) | AU2006215818A1 (es) |
| BR (1) | BRPI0606724A2 (es) |
| CA (1) | CA2590004A1 (es) |
| CR (1) | CR9324A (es) |
| DO (1) | DOP2006000035A (es) |
| EA (1) | EA200701091A1 (es) |
| IL (1) | IL183635A0 (es) |
| MX (1) | MX2007009061A (es) |
| NO (1) | NO20072687L (es) |
| PA (1) | PA8663401A1 (es) |
| PE (1) | PE20061291A1 (es) |
| TW (1) | TW200640468A (es) |
| UA (1) | UA85003C2 (es) |
| WO (1) | WO2006087173A1 (es) |
| ZA (1) | ZA200707910B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1774970A1 (de) * | 2005-10-13 | 2007-04-18 | Bayer Schering Pharma AG | Verfahren zur Herstellung eines einphasigen pharmazeutischen Präparates zur Therapie der dysfunktionellen uterinen Blutung, enthaltend Ethinylestradiol und Dienogest |
| DE102008051140B4 (de) * | 2007-10-11 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Verfahren zur Herstellung eines einphasischen pharmazeutischen Präparates zur Begrenzung/Minderung des Risikos einer Tiefen-Venen-Thrombose in Einheit mit einer oralen Kontrazeption |
| AT12800U1 (de) * | 2007-11-05 | 2012-11-15 | Bayer Schering Pharma Ag | Pharmazeutisches Präparat zur Verwendung bei der oralen Kontrazeption von Frauen mit Laktoseintoleranz |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998004269A1 (en) * | 1996-07-26 | 1998-02-05 | American Home Products Corporation | Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen |
-
2005
- 2005-02-15 EP EP05003179A patent/EP1690543A1/de not_active Withdrawn
-
2006
- 2006-02-13 DO DO2006000035A patent/DOP2006000035A/es unknown
- 2006-02-15 PE PE2006000182A patent/PE20061291A1/es not_active Application Discontinuation
- 2006-02-15 AU AU2006215818A patent/AU2006215818A1/en not_active Abandoned
- 2006-02-15 TW TW095105106A patent/TW200640468A/zh unknown
- 2006-02-15 WO PCT/EP2006/001354 patent/WO2006087173A1/de not_active Ceased
- 2006-02-15 EA EA200701091A patent/EA200701091A1/ru unknown
- 2006-02-15 CN CNA2006800048911A patent/CN101119732A/zh active Pending
- 2006-02-15 MX MX2007009061A patent/MX2007009061A/es not_active Application Discontinuation
- 2006-02-15 KR KR1020077013786A patent/KR20070086380A/ko not_active Ceased
- 2006-02-15 BR BRPI0606724-7A patent/BRPI0606724A2/pt not_active IP Right Cessation
- 2006-02-15 EP EP06706958A patent/EP1853273A1/de not_active Ceased
- 2006-02-15 UA UAA200709517A patent/UA85003C2/ru unknown
- 2006-02-15 PA PA20068663401A patent/PA8663401A1/es unknown
- 2006-02-15 JP JP2007551646A patent/JP2008527018A/ja not_active Withdrawn
- 2006-02-15 CA CA002590004A patent/CA2590004A1/en not_active Abandoned
- 2006-02-15 AR ARP060100527A patent/AR053545A1/es unknown
-
2007
- 2007-05-25 NO NO20072687A patent/NO20072687L/no not_active Application Discontinuation
- 2007-06-04 IL IL183635A patent/IL183635A0/en unknown
- 2007-08-17 CR CR9324A patent/CR9324A/es unknown
- 2007-09-14 ZA ZA200707910A patent/ZA200707910B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006087173A1 (de) | 2006-08-24 |
| EA200701091A1 (ru) | 2008-02-28 |
| UA85003C2 (ru) | 2008-12-10 |
| IL183635A0 (en) | 2007-10-31 |
| TW200640468A (en) | 2006-12-01 |
| CN101119732A (zh) | 2008-02-06 |
| PE20061291A1 (es) | 2006-12-07 |
| PA8663401A1 (es) | 2006-12-07 |
| MX2007009061A (es) | 2007-09-11 |
| AU2006215818A1 (en) | 2006-08-24 |
| BRPI0606724A2 (pt) | 2009-07-14 |
| CR9324A (es) | 2007-10-11 |
| EP1690543A1 (de) | 2006-08-16 |
| CA2590004A1 (en) | 2006-08-24 |
| KR20070086380A (ko) | 2007-08-27 |
| ZA200707910B (en) | 2009-08-26 |
| JP2008527018A (ja) | 2008-07-24 |
| AR053545A1 (es) | 2007-05-09 |
| NO20072687L (no) | 2007-11-13 |
| EP1853273A1 (de) | 2007-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20070188A2 (en) | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive | |
| ES2693085T1 (es) | Uso de estriol en bajas dosis | |
| CO6160297A2 (es) | Uso de valerato de estradiol o 17beta-estradiol en combinacion de dienogest en una terapia oral para mantener y/o incrementar la libido femenina | |
| AR084229A2 (es) | Preparado polifasico para la contracepcion a base de un estrogeno natural | |
| NO327588B1 (no) | Farmasoytisk sammensetning og preparat omfattende etinylostradiol og drospirenon for anvendelse som antikonsepsjonsmiddel | |
| AR049112A1 (es) | Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual | |
| CY1108265T1 (el) | Στερεη διαστοματικη φαρμακευτικη μορφη για αντισυλληψη | |
| CR9324A (es) | Preparación farmacéutica para la anticoncepción oral | |
| HRP20090256T1 (en) | Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method | |
| CY1110348T1 (el) | Φαρμακευτικη μορφη για ληψη απο του στοματος με dienogest και αιθινυλ-οιστραδιολη για αντισυλληψη | |
| UY29378A1 (es) | Preparación farmaceutica para la anticoncepción oral | |
| DOP2006000037A (es) | Forma farmacológica peroral sólida para la anticoncepción | |
| CY1112775T1 (el) | Χρηση βαλεριανικης οιστραδιολης σε συνδυασμο με dienogest για την απο του στοματος θεραπεια της δυσλειτουργικης αιμορραγιας της μητρας σε ενοτητα με αντισυλληψη απο του στοματος | |
| PE20091020A1 (es) | Uso de un gestageno en combinacion con un estrogeno y uno o varios excipientes/portadores farmaceuticamente aceptables para la anticoncepcion oral sin lactosa | |
| ECSP003721A (es) | Una composicion farmaceutica para ser usada como anticonceptivo | |
| TH80557A (th) | ผลิตภัณฑ์ทางเภสัชกรรมสำหรับการคุมกำเนิดทางช่องปาก | |
| TH148141A (th) | การใช้เอสตราไดออลวาเลอเรตหรือเอสตราไดออลร่วมกับไดอีโนเจสต์สำหรับการรักษาโดยให้ทางปากในการตกเลือดในมดลูกแบบที่ทำงานผิดปกติ ร่วมกับยาคุมกำเนิดสำหรับให้ทางปาก | |
| CR9240A (es) | Forma farmacologica peroral solida para la anticoncepcion | |
| PE20070769A1 (es) | Procedimiento para la produccion de una preparacion farmaceutica monofasica para la terapia oral de la hemorragia uterina disfuncional |